Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of large shareholdings)
10 Enero 2024 - 4:00PM
Press release Biocartis Group NV: Disclosure of transparency
notification (Article 14, first paragraph, of the Act of 2 May 2007
on the disclosure of large shareholdings)
BIOCARTIS GROUP NV (Euronext Brussels: BCART)
PRESS RELEASE - REGULATED INFORMATION - 10 January
2024, 23:00 CET
Disclosure of transparency
notification
(Article 14, first paragraph, of the Act of
2 May 2007 on the disclosure of large shareholdings)
1. Summary of notice
BIOCARTIS GROUP NV received a transparency
notification on January 5, 2024, of which an amended version was
received on January 8, 2024, showing that Invesco Ltd., with
registered office at 1331, Spring Street NW, Suite 2500, Atlanta,
Georgia 30309, USA, pursuant to the transfer of all its shares on
January 3, 2024, now that it no longer has any voting rights in the
company. It has thus downwards exceeded the participation threshold
of 3%.
2. Contents of the
notification
The amended notification dated January 8, 2024
contains the following information:
-
Reason for the notification:
-
Acquisition or disposal of voting securities or voting rights;
- Downward
crossing of the lowest threshold.
-
Notification by: A parent undertaking or a
controlling person.
-
Person(s) required to notify: Invesco Ltd., with
registered office at 1331, Spring Street NW, Suite 2500, Atlanta,
Georgia 30309, USA.
-
Date on which the threshold is crossed:
03-01-2024
-
Threshold crossed (in %): 3%
-
Denominator: 93,915,910
-
Notified details:
A) Voting rights attached to voting
securities |
Holders of voting rights |
Previous notice |
After the transaction |
Number of voting rights |
Number of voting rights |
% voting rights |
Related to securities |
Regardless of the effects |
Related to securities |
Regardless of the effects |
Invesco Ltd. |
0 |
0 |
0 |
0% |
0% |
Invesco Advisers Inc. |
9,240,331 |
0 |
0 |
0% |
0% |
TOTAL |
|
0% |
0% |
- Chain of
controlled undertakings through which the holding is effectively
held :This disclosure is made on behalf of Invesco Ltd.
and relates to shares beneficially owned by various mutual and
pension funds managed by Invesco Ltd. and its subsidiary companies,
whereby Invesco Ltd. has discretion as to the acquisition and
disposal of the shares and as to the exercise of the voting rights
associated with the shares. Invesco Ltd. is not a controlled
entity. Invesco Ltd. is the parent company controlling the voting
rights for Invesco Advisers, Inc.
- Additional
information:The acquisition of the shares in the
(company), by Invesco (on behalf of funds managed by affiliates of
the group management companies) to Invesco Ltd, is part of the
normal course of its portfolio management company activity,
conducted without intent to implement a particular strategy for the
company, or to exercise, as such, a specific influence on the
management of the latter. The company, Invesco (on behalf of funds
managed by affiliates of the group management companies) is not
acting in concert with a third party and does not intend to take
control of the company.
3.
Miscellaneous
This press release can be consulted on the website
of BIOCARTIS GROUP NV via this link Press releases | Biocartis
Group NV.
--- END ---
More information:
Investor Relations Biocartis Group
NVe-mail info@biocartisgroupnv.be
Biocartis and Idylla™ are registered trademarks in
Europe, the United States and other countries. The Biocartis and
Idylla™ trademark and logo are used trademarks owned by Biocartis.
Please refer to the product labeling for applicable intended uses
for each individual Biocartis product. This press release is not
for distribution, directly or indirectly, in any jurisdiction where
to do so would be unlawful. Any persons reading this press release
should inform themselves of and observe any such restrictions.
Biocartis takes no responsibility for any violation of any such
restrictions by any person. This press release does not constitute
an offer or invitation for the sale or purchase of securities in
any jurisdiction. No securities of Biocartis may be offered or sold
in the United States of America absent registration with the United
States Securities and Exchange Commission or an exemption from
registration under the U.S. Securities Act of 1933, as amended.
Forward-looking statements
Certain statements, beliefs and opinions in this
press release are forward-looking, which reflect the Company's or,
as appropriate, the Company directors' or managements' current
expectations and projections concerning future events such as the
Company's results of operations, financial condition, liquidity,
performance, prospects, growth, strategies and the industry in
which the Company operates. By their nature, forward-looking
statements involve a number of risks, uncertainties, assumptions
and other factors that could cause actual results or events to
differ materially from those expressed or implied by the
forward-looking statements. These risks, uncertainties, assumptions
and factors could adversely affect the outcome and financial
effects of the plans and events described herein. A multitude of
factors including, but not limited to, changes in demand,
competition and technology, can cause actual events, performance or
results to differ significantly from any anticipated development.
Forward-looking statements contained in this press release
regarding past trends or activities are not guarantees of future
performance and should not be taken as a representation that such
trends or activities will continue in the future. In addition, even
if actual results or developments are consistent with the
forward-looking statements contained in this press release, those
results or developments may not be indicative of results or
developments in future periods. No representations and warranties
are made as to the accuracy or fairness of such forward-looking
statements. As a result, the Company expressly disclaims any
obligation or undertaking to release any updates or revisions to
any forward-looking statements in this press release as a result of
any change in expectations or any change in events, conditions,
assumptions or circumstances on which these forward-looking
statements are based, except if specifically required to do so by
law or regulation. Neither the Company nor its advisers or
representatives nor any of its subsidiary undertakings or any such
person's officers or employees guarantees that the assumptions
underlying such forward-looking statements are free from errors nor
does either accept any responsibility for the future accuracy of
the forward-looking statements contained in this press release or
the actual occurrence of the forecasted developments. You should
not place undue reliance on forward-looking statements, which speak
only as of the date of this press release.
Biocartis Group NV (EU:BCART)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Biocartis Group NV (EU:BCART)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024